The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEIH.L Regulatory News (EIH)

  • There is currently no data for EIH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

26 Jan 2017 17:08

RNS Number : 2553V
EIH PLC
26 January 2017
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

EIH PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

Weiss Asset Management LP

4. Full name of shareholder(s)  (if different from 3.):iv

Brookdale International Partners, L.P., Brookdale Global Opportunity Fund[1]

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

Jan-24-2017, Jan-25-2017

6. Date on which issuer notified:

Jan-26-2017

7. Threshold(s) that is/are crossed orreached: vi, vii

> 13%, 14%, 15%, 16%, 17%, 18%, 19%, 20%, 21%, 22%, 23%, 24%, 25%, 26%, 27%, 28%, 29%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

IM00B1HYQW54

8,303,740

8,303,740

19,303,740

19,303,740

n/a

29.93 %

n/a

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

19,303,740

29.93 %

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

Brookdale International Partners, L.P.: 12,554,703 voting rights/financial instruments (19.46 %)

Brookdale Global Opportunity Fund: 6,749,037 voting rights/financial instruments (10.46 %)

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:

Please note: This notification is being furnished to the issuer pursuant to Article 82.1 of the issuer's Articles of Association dated 28 March 2011, and is not being filed with the FCA.

14. Contact name:

Georgiy Nikitin

15. Contact telephone number:

+1-617-778-7725

 

 


[1] Weiss Asset Management LP is the Investment Manager to Brookdale Global Opportunity Fund and Brookdale International Partners, L.P.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLPGUWUGUPMGMQ
Date   Source Headline
7th May 202011:49 amRNSResult of EGM and Notice of Cancellation
7th Apr 20207:00 amRNSProposed AIM Cancellation and Notice of EGM
2nd Apr 20205:38 pmRNSReturn of Capital and COVID-19 Update
6th Dec 20197:00 amRNSReturn of Capital
29th Nov 20197:00 amRNSDelisting Update
21st Nov 20197:00 amRNSMarket Update
30th Sep 20194:30 pmRNSInterim Results
30th Jul 201911:15 amRNSResult of AGM
28th Jun 20197:00 amRNSPosting of 2018 Annual Results and Notice of AGM
24th May 20195:53 pmRNSHolding(s) in Company
1st May 20197:00 amRNSReturn of Capital
4th Apr 20195:00 pmRNSSale of RSB and Return of Capital
25th Jan 20197:00 amRNSHolding(s) in Company
21st Jan 20196:13 pmRNSHolding(s) in Company
18th Jan 201911:37 amRNSHolding(s) in Company
28th Sep 20187:00 amRNSInterim Results
26th Jul 201811:05 amRNSResult of AGM
28th Jun 20187:00 amRNSPosting of 2017 Annual Report and Notice of AGM
28th Jun 20187:00 amRNSReturn of Capital
20th Mar 20181:00 pmRNSReplacement: Return of Capital
20th Mar 20187:00 amRNSReturn of Capital
29th Sep 20175:17 pmRNSHalf-year Report
29th Sep 20175:13 pmRNSReturn of capital
24th Jul 201710:54 amRNSResults of Annual General Meeting
26th Jun 20176:01 pmRNSDirectorate Change
26th Jun 20176:00 pmRNSPosting of 2016 Annual Report and Notice of AGM
9th Feb 20178:05 amRNSReturn of Capital
26th Jan 20175:08 pmRNSHolding(s) in Company
25th Jan 20179:30 amRNSHolding(s) in Company
5th Jan 20177:00 amRNSUpdate re EIF
30th Sep 20167:00 amRNSHalf-year Report
25th Jul 20161:24 pmRNSResult of AGM
27th Jun 20165:37 pmRNSPosting of Annual Report & Notice of AGM
27th Jun 20167:00 amRNSFinal Results
27th Jun 20167:00 amRNSReturn of Capital
30th Nov 20155:57 pmRNSHolding(s) in Company
30th Sep 20157:00 amRNSInterim Results
30th Jun 201511:53 amRNSResult of AGM
9th Jun 20154:00 pmRNSNotice of AGM
5th Jun 20154:35 pmRNSFinal Results
30th Sep 20147:00 amRNSHalf Yearly Report
14th Jul 20143:19 pmRNSReturn of Capital
30th Jun 201411:57 amRNSResult of AGM
4th Jun 20147:00 amRNSNotice of AGM
3rd Jun 20147:00 amRNSFinal Results
3rd Dec 201311:16 amRNSHolding(s) in Company
2nd Dec 20134:09 pmRNSHolding(s) in Company
28th Nov 20135:14 pmRNSHolding(s) in Company
27th Nov 20133:14 pmRNSSale of Interest in Gland Pharma Limited
22nd Nov 20139:15 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.